Visa vs Mastercard: Which Is the Better Buy This Year
Visa and Mastercard posted stronger-than-expected Q1 results as cross-border spending rebounds. The key question for ...
Investing
This page offers a collection of 17 insightful articles on investing, covering strategies, market trends, and expert tips to enhance your financial journey.
15,957 articles
Surprising More Yield (And Less Volatility) Than Treasuries in 2026
A fresh investing approach blends emerging-market debt with high-quality short bonds to deliver higher income and ste...
IonQ, Rigetti, D-Wave: Quantum Rally Reverses Today
A broad sell-off hit four key quantum names after a sharp Monday rally, with profit-taking and sentiment shifts weigh...
Diagnosed with a Serious Illness at 62: Claiming Now
A 62-year-old diagnosed with serious illness chooses to take Social Security now rather than wait until 70, highlight...
DGP vs UGL: Which 2x Gold Play Costs You More
Two leveraged gold bets, DGP and UGL, jump with gold but carry different risk profiles. This analysis explains the st...
Insider: Iran Deal Isn’t Good News for Mortgages Today
News of a potential Iran peace deal sends crude prices lower, but mortgage rates look headed for a slower drop as inf...
Palantir Down 2026 Despite Upgrade Faces Valuation Hurdle
Palantir stock drifted lower again in 2026 after Wolfe Research moved the stock to a neutral stance. The move comes a...
Figma Stock Poised Upside: Markets Rally Amid AI Push
Figma is showing early signs of revival after a volatile debut, with improving revenue growth and expanding enterpris...
Massive Multi-Billion-Dollar Industry Merger Reframes McCormick
A landmark massive multi-billion-dollar industry merger is reshaping how investors view McCormick, nudging it from a ...
Buy, Hold, Sell: Just IBM Stock Looks Attractive Now
IBM has fallen roughly 16% from its January peak as cash flow improves and software growth accelerates. This piece we...
Here Is the Unstoppable Billion Growth Engine for Investors
A single company’s three engines—cloud, ads, and chips—are powering a persistent multi‑billion revenue trajectory, ev...
AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Related Topics
#Stock Market (2704)
#AI (1894)
#Stock Analysis (1639)
#Personal Finance (1307)
#ETFs (1095)
#Earnings (1058)
#Retirement Planning (1056)
#Tech Stocks (1041)
#Portfolio Management (999)
#Stocks (995)
#Semiconductors (893)
#Markets (791)
#Market News (778)
#Portfolio Strategy (630)
#Market Trends (523)